Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Editorial

Metabolic dysfunction in patients following DAA-induced viral cure for HCV infection: A non-negligible risk to liver-related health: Editorial on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C”

Chen-Hua Liu, Yu-Ping Chang

Clin Mol Hepatol. 2025;31(2):658-661. Published online February 17, 2025

DOI: https://doi.org/10.3350/cmh.2025.0155

View: 341 Download: 33 Crossref: 2

Letter to the Editor

The fibrosis-4 index for advanced liver fibrosis in NAFLD with T2DM: Half a loaf is better than no bread

Zeyu Wang, Dong Wan, Meidong Xu, Yong Jiang

Clin Mol Hepatol. 2025;31(1):e25-e26. Published online December 10, 2024

DOI: https://doi.org/10.3350/cmh.2024.0993

View: 824 Download: 38

Original Article

Diagnostic accuracy of the Fibrosis-4 index for advanced liver fibrosis in nonalcoholic fatty liver disease with type 2 diabetes: A systematic review and meta-analysis

Ji Won Han, Hee Yeon Kim, Jung Hwan Yu, Mi Na Kim, Young Eun Chon, Ji Hyun An, Young-Joo Jin, Miyoung Choi, Seung Up Kim, Han Ah Lee, Dae Won Jun

Clin Mol Hepatol. 2024;30(Suppl):S147-S158. Published online July 25, 2024

DOI: https://doi.org/10.3350/cmh.2024.0330

View: 2263 Download: 137 Web of Science: 4 Crossref: 5

Elevated red cell distribution width is associated with advanced fibrosis in NAFLD

Hwa Mok Kim, Bum Soo Kim, Yong Kyun Cho, Byung Ik Kim, Chong Il Sohn, Woo Kyu Jeon, Hong Joo Kim, Dong Il Park, Jung Ho Park, Kwan Joong Joo, Chang Joon Kim, Yong Sung Kim, Woon Je Heo, Won Seok Choi

Clin Mol Hepatol. 2013;19(3):258-265. Published online September 30, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.3.258

View: 11036 Download: 110 Crossref: 35

1 |

Viewed By 8228	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7282	MAFLD: How is it different from NAFLD?
Viewed By 5269	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4926	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4512	Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease

Cited By 319	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 288	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 186	MAFLD: How is it different from NAFLD?
Cited By 101	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 92	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search